363 related articles for article (PubMed ID: 26291965)
41. Population structure and mouse-virulence of Toxoplasma gondii in Brazil.
Pena HF; Gennari SM; Dubey JP; Su C
Int J Parasitol; 2008 Apr; 38(5):561-9. PubMed ID: 17963770
[TBL] [Abstract][Full Text] [Related]
42. A conserved non-canonical motif in the pseudoactive site of the ROP5 pseudokinase domain mediates its effect on Toxoplasma virulence.
Reese ML; Boothroyd JC
J Biol Chem; 2011 Aug; 286(33):29366-29375. PubMed ID: 21708941
[TBL] [Abstract][Full Text] [Related]
43. Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins.
Grzybowski MM; Dziadek B; Gatkowska JM; Dzitko K; Długońska H
Parasitol Res; 2015 Dec; 114(12):4553-63. PubMed ID: 26337271
[TBL] [Abstract][Full Text] [Related]
44. A monomorphic haplotype of chromosome Ia is associated with widespread success in clonal and nonclonal populations of Toxoplasma gondii.
Khan A; Miller N; Roos DS; Dubey JP; Ajzenberg D; Dardé ML; Ajioka JW; Rosenthal B; Sibley LD
mBio; 2011; 2(6):e00228-11. PubMed ID: 22068979
[TBL] [Abstract][Full Text] [Related]
45. Identification of small molecule inhibitors that block the
Simpson C; Jones NG; Hull-Ryde EA; Kireev D; Stashko M; Tang K; Janetka J; Wildman SA; Zuercher WJ; Schapira M; Hui R; Janzen W; Sibley LD
ACS Infect Dis; 2016 Mar; 2(3):194-206. PubMed ID: 27379343
[TBL] [Abstract][Full Text] [Related]
46. WITHDRAWN: Toxoplasma gondii virulence factor ROP18 inhibits the host NF-κB pathway by promoting p65 degradation.
Du J; An R; Chen L; Shen Y; Chen Y; Cheng L; Jiang Z; Zhang A; Yu L; Chu D; Shen Y; Luo Q; Chen H; Wan L; Li M; Xu X; Shen J
J Biol Chem; 2014 May; 289(18):12578-92. PubMed ID: 24648522
[TBL] [Abstract][Full Text] [Related]
47. Genetic analyses of Chinese isolates of Toxoplasma gondii reveal a new genotype with high virulence to murine hosts.
Gao JM; Xie YT; Xu ZS; Chen H; Hide G; Yang TB; Shen JL; Lai DH; Lun ZR
Vet Parasitol; 2017 Jul; 241():52-60. PubMed ID: 28579032
[TBL] [Abstract][Full Text] [Related]
48. Early immune response to
Uzelac A; Klun I; Djurković-Djaković O
Front Cell Infect Microbiol; 2024; 14():1414067. PubMed ID: 38912206
[TBL] [Abstract][Full Text] [Related]
49. Reciprocal virulence and resistance polymorphism in the relationship between Toxoplasma gondii and the house mouse.
Lilue J; Müller UB; Steinfeldt T; Howard JC
Elife; 2013 Oct; 2():e01298. PubMed ID: 24175088
[TBL] [Abstract][Full Text] [Related]
50. Isolation, genotyping and pathogenicity of a Toxoplasma gondii strain isolated from a Serval (Leptailurus serval) in China.
Dong H; Su R; Li T; Su C; Zhang L; Yang Y
Transbound Emerg Dis; 2019 Jul; 66(4):1796-1802. PubMed ID: 31102311
[TBL] [Abstract][Full Text] [Related]
51. Gene sequence and transcription differences in 70 kDa heat shock protein correlate with murine virulence of Toxoplasma gondii.
Lyons RE; Johnson AM
Int J Parasitol; 1998 Jul; 28(7):1041-51. PubMed ID: 9724875
[TBL] [Abstract][Full Text] [Related]
52. Hammondia hammondi, an avirulent relative of Toxoplasma gondii, has functional orthologs of known T. gondii virulence genes.
Walzer KA; Adomako-Ankomah Y; Dam RA; Herrmann DC; Schares G; Dubey JP; Boyle JP
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7446-51. PubMed ID: 23589877
[TBL] [Abstract][Full Text] [Related]
53. [Construction and Identification of Transgenic Strain of Toxoplasma gondii High-expressing Virulence Factor ROP18].
Jiang ZR; An R; Yang J; Wan LJ; Du J
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2015 Feb; 33(1):14-8. PubMed ID: 26080519
[TBL] [Abstract][Full Text] [Related]
54. The Toxoplasma pseudokinase ROP5 is an allosteric inhibitor of the immunity-related GTPases.
Reese ML; Shah N; Boothroyd JC
J Biol Chem; 2014 Oct; 289(40):27849-58. PubMed ID: 25118287
[TBL] [Abstract][Full Text] [Related]
55.
Subekti DT; Ekawasti F; Desem MI; Azmi Z
J Vet Sci; 2021 Nov; 22(6):e88. PubMed ID: 34854270
[No Abstract] [Full Text] [Related]
56. Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii.
Steinfeldt T; Könen-Waisman S; Tong L; Pawlowski N; Lamkemeyer T; Sibley LD; Hunn JP; Howard JC
PLoS Biol; 2010 Dec; 8(12):e1000576. PubMed ID: 21203588
[TBL] [Abstract][Full Text] [Related]
57. Description of an atypical Toxoplasma gondii isolate from a case of congenital toxoplasmosis in northeastern Brazil.
de Melo RPB; Wanderley FS; Porto WJN; Pedrosa CM; Hamilton CM; de Oliveira MHGS; Ribeiro-Andrade M; Rêgo RCDS; Katzer F; Mota RA
Parasitol Res; 2020 Aug; 119(8):2727-2731. PubMed ID: 32518965
[TBL] [Abstract][Full Text] [Related]
58. Toxoplasma gondii: cloning, expression and immunoreactivity of recombinant ROP5 and ROP18 antigens.
Grzybowski MM; Dziadek B; Dziadek J; Gatkowska J; Dzitko K; Długońska H
Exp Parasitol; 2015 Mar; 150():1-6. PubMed ID: 25592730
[TBL] [Abstract][Full Text] [Related]
59. Naïve CD8 T cell IFNγ responses to a vacuolar antigen are regulated by an inflammasome-independent NLRP3 pathway and Toxoplasma gondii ROP5.
Kongsomboonvech AK; Rodriguez F; Diep AL; Justice BM; Castallanos BE; Camejo A; Mukhopadhyay D; Taylor GA; Yamamoto M; Saeij JPJ; Reese ML; Jensen KDC
PLoS Pathog; 2020 Aug; 16(8):e1008327. PubMed ID: 32853276
[TBL] [Abstract][Full Text] [Related]
60. Influence of Two Major
Hernández-de-Los-Ríos A; Murillo-Leon M; Mantilla-Muriel LE; Arenas AF; Vargas-Montes M; Cardona N; de-la-Torre A; Sepúlveda-Arias JC; Gómez-Marín JE
Front Cell Infect Microbiol; 2019; 9():413. PubMed ID: 31867288
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
